Detailed information for compound 1826582

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 449.976 | Formula: C25H28ClN5O
  • H donors: 1 H acceptors: 2 LogP: 4.43 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCc1ccc(cc1)/C=N/NC(=O)CCN1CCN(CC1)c1ccnc2c1ccc(c2)Cl
  • InChi: 1S/C25H28ClN5O/c1-2-19-3-5-20(6-4-19)18-28-29-25(32)10-12-30-13-15-31(16-14-30)24-9-11-27-23-17-21(26)7-8-22(23)24/h3-9,11,17-18H,2,10,12-16H2,1H3,(H,29,32)/b28-18+
  • InChiKey: WOVHNNXGMJZBIM-MTDXEUNCSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis ap endonuclease, putative 0.001 0.5774 0.5
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.001 0.5774 0.5
Leishmania major apurinic/apyrimidinic endonuclease-redox protein 0.001 0.5774 1
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.001 0.5774 0.5
Echinococcus multilocularis DNA (apurinic or apyrimidinic site) lyase 0.001 0.5774 0.5
Loa Loa (eye worm) cytochrome P450 family protein 0.0014 1 1
Trypanosoma cruzi apurinic/apyrimidinic endonuclease, putative 0.001 0.5774 1
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.001 0.5774 0.5
Loa Loa (eye worm) exodeoxyribonuclease III family protein 0.001 0.5774 0.5774
Echinococcus granulosus DNA apurinic or apyrimidinic site lyase 0.001 0.5774 0.5
Schistosoma mansoni ap endonuclease 0.001 0.5774 0.5
Trypanosoma cruzi apurinic/apyrimidinic endonuclease 0.001 0.5774 1
Entamoeba histolytica exodeoxyribonuclease III, putative 0.001 0.5774 0.5
Loa Loa (eye worm) cytochrome P450 family protein 0.0008 0.4068 0.4068
Loa Loa (eye worm) cytochrome P450 family protein 0.0008 0.4068 0.4068
Trichomonas vaginalis ap endonuclease, putative 0.001 0.5774 0.5
Toxoplasma gondii exonuclease III APE 0.001 0.5774 0.5
Brugia malayi exodeoxyribonuclease III family protein 0.001 0.5774 0.2876
Schistosoma mansoni ap endonuclease 0.001 0.5774 0.5
Loa Loa (eye worm) CYP4Cod1 0.0008 0.4068 0.4068
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.001 0.5774 0.5
Trypanosoma brucei apurinic/apyrimidinic endonuclease, putative 0.001 0.5774 1
Treponema pallidum exodeoxyribonuclease (exoA) 0.001 0.5774 0.5
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.001 0.5774 1
Giardia lamblia Endonuclease/Exonuclease/phosphatase 0.001 0.5774 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 11.1 uM Antiprotozoal activity against Entamoeba histolytica HM-1:IMSS trophozoites after 72 hrs by microdilution method ChEMBL. 24530492
Inhibition (functional) = 97.8 % Antimicrobial activity against erythrocytic stage of chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes assessed as [3H]hypoxanthine incorporation at 1 ug/ml after 24 hrs by beta-radiation counting analysis ChEMBL. 24530492

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Entamoeba histolytica 24530492

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.